Cardiology
RSSArticles
-
Internal Medicine Alert: Full March 29, 2009 Issue in PDF
-
Febuxostat Tablets (Uloric®)
The first new urate-lowering drug has been approved in more than 40 years. -
New rules for opioid prescribing
The FDA is considering new tightened restrictions on use of opioid drugs. Manufacturers of these drugs will be required to have a Risk Evaluation and Mitigation Strategy to ensure that "the benefits of the drugs continue to outweigh the risks." -
Individualization with pharmacogenetics
Get used to the word "pharmacogenetics" — the discipline of studying genetic variation and its effect on responses to drugs. -
Full April 1, 2009 Issue in PDF
-
FDA Actions
The FDA has issued a public health advisory regarding the risk of progressive multifocal leukoencephalopathy (PML) associated with use of efalizumab (Raptiva®) for the treatment of psoriasis. -
The rate vs rhythm debate
Rate control vs rhythm control for atrial fibrillation continues to be debated with most of the evidence falling on the side of rate control in recent years, primarily because of adverse effects from anti-arrhythmics. A new drug may change that however. -
Full March 15, 2009 Issue in PDF
-
Priming the Pump of a Leaky Gut
This is the first study documenting that a PPI compromises the mucosal barrier function of the upper GI tract. -
ECG Review: What Happened in the Past?
The ECG shown above was a baseline tracing obtained during the initial visit with a new primary care provider. How would you interpret the tracing? What do you suspect happened in the past?